Bioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals; Drug: ADVAIR DISKUS® 250/50 Sponsors: Respirent Pharmaceuticals Co Ltd.; Becro Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma
Condition: Asthma Interventions: Drug: QVM149; Drug: Salmeterol Xinafoate / Fluticasone Propionate; Drug: Placebo to QVM149; Drug: Placebo to Salmeterol Xinafoate / Fluticasone Propionate; Drug: Run-In Medication; Drug: Rescue Medication; Device: Concept 1 Device; Device: Girohaler Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials
